TRA16 and , can be viewed by using the sample data set available at the TraceHaplotyper homepage. The TRA16 is an example of an indel followed by a single SNP. TraceHaplotyper is also able to analyze a situation in which two SNPs follow the indel.
Haplotypes were constructed successfully for the GRAMD3 locus even when the SNP site was as much as 171 bp downstream from the site of the indel. However, the quality of the trace and base calling may affect the result because the program is not designed to contend with deviation from the expected pattern of more than one base. The program is unlikely to be able to align the expected and the trace sequences of low-quality traces with such deviations.
Organism species: Homo sapiens (Human)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant HCV NS3 Transactivated Protein 2 (NS3TP2) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to HCV NS3 Transactivated Protein 2 (NS3TP2) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to HCV NS3 Transactivated Protein 2 (NS3TP2) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for HCV NS3 Transactivated Protein 2 (NS3TP2) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for HCV NS3 Transactivated Protein 2 (NS3TP2) | ELISA Kit Customized Service Offer |
Organism species: Mus musculus (Mouse)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant HCV NS3 Transactivated Protein 2 (NS3TP2) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to HCV NS3 Transactivated Protein 2 (NS3TP2) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to HCV NS3 Transactivated Protein 2 (NS3TP2) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for HCV NS3 Transactivated Protein 2 (NS3TP2) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for HCV NS3 Transactivated Protein 2 (NS3TP2) | ELISA Kit Customized Service Offer |
Organism species: Rattus norvegicus (Rat)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant HCV NS3 Transactivated Protein 2 (NS3TP2) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to HCV NS3 Transactivated Protein 2 (NS3TP2) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to HCV NS3 Transactivated Protein 2 (NS3TP2) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for HCV NS3 Transactivated Protein 2 (NS3TP2) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for HCV NS3 Transactivated Protein 2 (NS3TP2) | ELISA Kit Customized Service Offer |
- "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
- "The DNA sequence and comparative analysis of human chromosome 5." Nature 431:268-274(2004) [PubMed] [Europe PMC] [Abstract]
- "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
- "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
- "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis."J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract]
- "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
- "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
- "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
- "N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB."Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012) [PubMed] [Europe PMC] [Abstract]